Local therapy outcomes and toxicity from the ATEMPT Trial (TBCRC 033), a phase II randomized trial of adjuvant T-DM1 vs. TH in women with stage I HER2 positive breast cancer Meeting Abstract
| Authors: | Bellon, J. R.; Tayob, N.; Burstein, H. J.; Partridge, A.; Demeo, M. K.; Tralins, J.; Yang, D. D.; Dang, C.; Isakoff, S. J.; Yardley, D.; Valero, V.; Winer, E.; Krop, I.; Tolaney, S. |
| Abstract Title: | Local therapy outcomes and toxicity from the ATEMPT Trial (TBCRC 033), a phase II randomized trial of adjuvant T-DM1 vs. TH in women with stage I HER2 positive breast cancer |
| Meeting Title: | 63rd Annual Meeting of the American Society for Radiation Oncology (ASTRO 2021) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 111 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Oct 24-27 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-11-01 |
| Start Page: | S34 |
| Language: | English |
| ACCESSION: | WOS:000715803801406 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2021.07.103 |
| Notes: | Meeting Abstract: 65 -- Source: Wos |
